Director, Head and Neck Cancer Program and Clinic
Providence Cancer Institute
Dr. Bell is an Oral and Maxillofacial Surgeon whose clinical activity, teaching and research is devoted entirely to the comprehensive surgical management of patients with head and neck cancer and craniomaxillofacial deformity. Dr. Bell has pioneered the use of virtual surgical planning and was one of the first surgeons on the U.S. west coast to perform transoral robotic surgery for the treatment of oropharyngeal cancer.
Dr. Bell is Director of the Providence Head and Neck Cancer Program and Clinic at Providence Cancer Institute, where he also directs a Fellowship in Head and Neck Oncologic and Microvascular Reconstructive Surgery; an Associate Member of the Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center; Attending Trauma Surgeon at Legacy Emanuel Medical Center; Clinical Professor at Oregon Health & Science University; and Consultant at The Head and Neck Institute, Portland, Oregon. He has served in leadership positions for numerous professional societies, boards, foundations and committees and is Past President of the American College of Oral and Maxillofacial Surgeons and a Founder and Past President of the American Academy of Craniomaxillofacial Surgeons.
Dr. Bell's research efforts are currently directed toward promoting the application of novel findings to the clinic and the design of therapeutic clinical trials to enhance anti-tumor immunity in head and neck cancer. Dr. Bell has fostered an institutional commitment to head and neck cancer immunotherapy research through numerous collaborations with scientists at the Earle A. Chiles Research Institute. Using his surgical practice to run phase I and phase II trials studying reversal of immunosuppression through monoclonal antibody therapy to enhance surgical resection, Dr. Bell bridges basic, translational and clinical activities. His work has resulted in over 150 scientific articles and book chapters, and he is co-editor of two major textbooks, including "Oral, Head and Neck Oncology and Reconstructive Surgery" and "Current Therapy in Oral and Maxillofacial Surgery". He has given more than 250 invited lectures, highlighting his interests in virtual surgical planning for craniomaxillofacial surgery, transoral robotic surgery and immunotherapy for head and neck cancer. Among his honors, Dr. Bell is a recipient of the William F. Harrigan Award for major contributions to surgery.
Disclosure: Stryker Craniomaxillofacial Inc.: Consultant/Advisory Board, Speaker/Honoraria
Thursday, September 19
1:20 PM – 1:40 PM